Manual of Traumatic Brain Injury, Third Edition : Assessment and Management (3RD)

The third edition of Manual of Traumatic Brain Injury offers a thorough revision of the popular evidence-based guide to understanding and managing all levels of traumatic brain injury. Comprehensive in scope and concise in format, this reference describes the spectrum of injury from mild to severe and the continuum of care from initial injury to management of chronic sequelae. Chapters are designed with a practical clinical focus for targeted retrieval of content by topic area and for self-review. The text is organized into five sections. Part I addresses fundamental concepts necessary for understanding the underpinning of clinical decision-making. Part II is dedicated to mild TBI, including sport-related concussion, with chapters covering topics from natural history to associated somatic disorders, post-concussion syndrome, and PTSD. Part III covers moderate to severe TBI and details prehospital emergency and ICU care, rehabilitation, treatment of related conditions, and postinjury outcomes. Part IV focuses on TBI-related complications, including posttraumatic seizures, spasticity, behavioral and sleep disturbances, and chronic traumatic encephalopathy (CTE). Part V reviews special considerations in selected populations such as pediatric TBI and TBI in the military, as well as medicolegal and ethical considerations in TBI, complementary and alternative medicine, and return to work considerations. Each chapter includes boxed Key Points which underscore major clinical takeaways, Study Questions to facilitate self-assessment and further emphasize core chapter content, and an Additional Reading list for a deeper dive into chapter concepts. Significant updates incorporating recent advancements in the field, combined with the clinical acumen of its experienced contributors, make this third edition the essential manual for healthcare professionals caring for individuals with traumatic brain injury. Key Features: Succinct format encourages targeted access to key clinical i